Crumdale
Insights
Matthew Naylor: 2020 Finalist for Entrepreneur of the Year
Matthew Naylor: 2020 Finalist for Entrepreneur of the YearEY Announces Matthew S. Naylor of Crumdale Partners as an Entrepreneur Of The Year® 2020 Greater Philadelphia Award Finalist Celebrating the unstoppable entrepreneurs whose ambitions transform our world Ernst...
COVID-19 Insights & Estimated Impact on Health Plans
COVID-19 Insights & Estimated Impact on Health PlansThese certainly are unprecedented times as individuals, companies and governments take steps to slow the spread of COVID 19 in an attempt to make sure the pandemic does not overwhelm our nation’s medical...
Employee Spotlight: Jason Lohman
Employee Spotlight: Jason Lohman Chief Operation Officer, Crumdale Partners’ Pharmacy Division (Transformation Rx) Jason Lohman has recently joined Crumdale Partners as the Chief Operating Officer of Crumdale Partners’ Pharmacy Division (Transformation Rx). His...
High-Deductible Health Plans May Now Waive Cost Share for Coronavirus Tests
High-Deductible Health Plans May Now Waive Cost Share for Coronavirus TestsOn March 11th, the Internal Revenue Service (IRS) announced that high-deductible health plans (HDHPs) can pay first dollar coverage for 2019 Novel Coronavirus (COVID-19)-related testing and...
Employers Begin Taking Steps to Combat the Coronavirus
Employers Begin Taking Steps to Combat the Coronavirus It is estimated over 75,000 people worldwide have been infected with the coronavirus, with death figures approaching 2800 people. The fear of this potentially deadly virus has employers beginning to take steps to...
FDA Approves First Medication for Treatment of Peanut Allergy
FDA Approves First Medication for Treatment of Peanut AllergyOn January 31st, 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia to reduce the risk of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts....
New Year = New Medication Price Increases
New Year = New Medication Price Increases Starting January 1st, over 550 medications increased their price a median 5% according to a report by 3 Axis Advisors. More price increases are expected over the next few weeks. Many drug manufactures have pledged to not...
FDA Drafts Guidance for Importation of Medications
FDA Drafts Guidance for Importation of Medications On December 17, 2019, The Food and Drug Administration (FDA) proposed guidance for the importation of medications from Canada. The goal of this proposal is to allow patients access to FDA approved medications from...
New Proposed Rules would Significantly Increase Hospital/Insurer Price Transparency for Employers
New Proposed Rules would Significantly Increase Hospital/Insurer Price Transparency for Employers The U.S. Department of Health and Human Services recently released two sets of regulations that would make health care costs publicly available. These regulations could...
Drug Watch: Treatments for Peanut Allergies
Drug Watch: Treatments for Peanut AllergiesThe U.S. Food and Drug Administration (FDA) is expected to decide on two new peanut allergy therapies in the next 6 months. These emerging medications are expected shift how patients with this condition are treated. The...